Medtronic starts U.S. Hugo RAS gynecology IDE study
Medtronic initiated a U.S. IDE clinical study evaluating the Hugo robotic-assisted surgery system for gynecological procedures.
Evidence notes
- The Embrace Gynecology study became Medtronic’s third U.S. IDE clinical study for Hugo RAS.
- Medtronic said the study supported its strategy to pursue multiple U.S. indications for Hugo RAS.
- The approval supports Medtronic starts U.S. Hugo RAS gynecology IDE study's path toward fielded use in commercial automation and autonomous-system workflows.
Company context
Medtronic is a global medical technology company with surgical robotics exposure through the Hugo robotic-assisted surgery system.